Status:
COMPLETED
Non-interventional Study on Oral Contraception Not Containing Ethinylestradiol (EE) to Assess Continuation Rates and Satisfaction
Lead Sponsor:
Bayer
Conditions:
Contraceptives, Oral
Eligibility:
FEMALE
18-50 years
Brief Summary
Prospective, non-interventional, multi-center study. Each subject will be followed for up to twelve months during the treatment with oral hormonal contraceptives(Qlaira ® or a Progestin Only Pill). Fo...
Eligibility Criteria
Inclusion
- Women between 18-50 years
- Women who used ethinylestradiol containing oral contraceptives for at least the three preceding months before the study
- Women who decided to start Qlaira® or a Progestin Only Pill. The prescription of the hormonal contraceptive is made at the discretion of the attending physician and has to be documented
Exclusion
- Contraindications and warnings of the respective Summary of Product Characteristics (Qlaira® or Progestin Only Pill)
- Women who are breast-feeding
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
3258 Patients enrolled
Trial Details
Trial ID
NCT01200186
Start Date
October 1 2010
End Date
October 1 2014
Last Update
October 16 2015
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Czechia
2
Many Locations, France
3
Many Locations, Germany
4
Many Locations, Greece